BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12731628)

  • 1. Histology of nerves and muscles in adductor spasmodic dysphonia.
    Chhetri DK; Blumin JH; Vinters HV; Berke GS
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
    Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
    Ludlow CL; Naunton RF; Fujita M; Sedory SE
    Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
    Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
    Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
    Bielamowicz S; Ludlow CL
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
    Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
    Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia.
    Fritzell B; Hammarberg B; Schiratzki H; Haglund S; Knutsson E; Mårtensson A
    J Voice; 1993 Jun; 7(2):172-8. PubMed ID: 8353632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia.
    Meleca RJ; Hogikyan ND; Bastian RW
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):487-92. PubMed ID: 9374172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of Laryngeal Electromyography in Spasmodic Dysphonia Diagnosis and Therapy.
    Yang Q; Xu W; Li Y; Cheng L
    Ann Otol Rhinol Laryngol; 2015 Jul; 124(7):579-83. PubMed ID: 25673120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teaching video NeuroImage: Spasmodic dysphonia: adductor and abductor.
    Reich SG; Meyer T
    Neurology; 2008 May; 70(19):e78. PubMed ID: 18458222
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy.
    Murry T; Woodson GE
    J Voice; 1995 Dec; 9(4):460-5. PubMed ID: 8574315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
    Davidson BJ; Ludlow CL
    Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for the treatment of spasmodic dysphonia.
    Gibbs SR; Blitzer A
    Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
    Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.